Internal Medicine | Page 224 of 487 | Links Medicus Content Curation & Alerts in Medicine

Rationing in #pandemic? Consider
1⃣identify scarce resources
2⃣exhaust ways to integrate
3⃣be clear/involve public
4⃣prognosis/age
5⃣responsibilities
6⃣pt goals/choice
7⃣disabilities, poverty, racism
8⃣prioritize
9⃣legal coverage
🔟impact on HCWs#COVID19 https://t.co/iSWVbqH3FY pic.twitter.com/bIoYmsSKQD

— Intensive Care Medicine (@yourICM) March 7, 2021

Podcast: Peripheral Artery Disease

9 Mar, 2021 | 02:18h | UTC

#260 Peripheral Artery Disease with Dr. Vlad Lakhter – The Curbsiders

Clinical Update: Diagnosis and treatment of irritable bowel syndrome

9 Mar, 2021 | 02:21h | UTC

Diagnosis and Treatment of Irritable Bowel Syndrome: A Review – JAMA (free for a limited period)

Podcast: Irritable Bowel Syndrome—Diagnosis and Treatment – JAMA

Cohort study: Elevated blood pressures are common in the emergency department but are they important?

9 Mar, 2021 | 02:04h | UTC

Yes, Your BP Is Up. No, It Doesn’t Matter. – Journal Feed

Original study: Elevated Blood Pressures Are Common in the Emergency Department but Are They Important? A Retrospective Cohort Study of 30,278 Adults – Annals of Emergency Medicine (link to abstract – $ for full-text)

Study: Balanced crystalloids vs. saline in critically ill adults with hyperkalemia or acute kidney injury

9 Mar, 2021 | 02:05h | UTC

Can We Use LR for Hyperkalemia? – Journal Feed

Original study: Balanced Crystalloids versus Saline in Critically Ill Adults with Hyperkalemia or Acute Kidney Injury: Secondary Analysis of a Clinical Trial – American Journal of Respiratory and Critical Care Medicine

Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice

7 Mar, 2021 | 19:20h | UTC

Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice – Heart

RCT: Half-dose vs. full-dose Edoxaban in 14,014 patients with Atrial Fibrillation

7 Mar, 2021 | 19:13h | UTC

Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation – Journal of the American College of Cardiology

Commentary: Lower Dose of Edoxaban Supported in ENGAGE-AF-TIMI 48 Analysis – TCTMD

RECOVERY trial: Colchicine arm stopped for lack of efficacy in patients hospitalized with COVID-19

7 Mar, 2021 | 20:16h | UTC

RECOVERY trial closes recruitment to colchicine treatment for patients hospitalised with COVID-19 – University of Oxford

Commentary: Cochicine does not improve mortality in COVID19 – St Emlyn’s

Commentary on Twitter

RECOVERY trial update:

Colchicine arm stopped for lack of efficacy in patients hospitalised with COVID-19.https://t.co/hcn9PytegJ pic.twitter.com/q09eddYXYL

— Martin Landray (@MartinLandray) March 5, 2021

RCT: Azithromycin provides no benefit for community treatment of patients with suspected COVID-19

7 Mar, 2021 | 20:15h | UTC

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial – The Lancet

Commentary on Twitter

The PRINCIPLE trial publishes its first peer reviewed paper, showing results from the study of azithromycin as a treatment for Covid-19 in the community. @TheLancet #UrgentCovidResearch #PRINCIPLETrial
👉https://t.co/qKRI5PVpQk pic.twitter.com/BVQztDSvSC

— OxPrimaryCareSci (@OxPrimaryCare) March 5, 2021

Mask mandates and restaurant restrictions tied to fewer Covid-19 illnesses and deaths, CDC study says

7 Mar, 2021 | 20:07h | UTC

Mask mandates and restaurant restrictions tied to fewer Covid-19 illnesses and deaths, CDC study says – CNN

Original study: Association of State-Issued Mask Mandates and Allowing On-Premises Restaurant Dining with County-Level COVID-19 Case and Death Growth Rates — United States, March 1–December 31, 2020 – CDC Morbidity and Mortality Weekly Report

Commentary on Twitter

A new @CDCMMWR finds that state-issued mask requirements are associated with the slowing of #COVID19 cases and deaths. Wearing a well-fitting mask consistently and correctly is one of the best ways we can protect ourselves and each other. Learn more: https://t.co/8YtmIMPMY0. pic.twitter.com/BLb56SGb2g

— CDC (@CDCgov) March 5, 2021

[Preprint] Genomics and epidemiology of a novel SARS-CoV-2 lineage P.1 – “P.1 may be 1.4–2.2 times more transmissible and 25-61% more likely to evade protective immunity elicited by previous infection with non-P.1 lineages”

7 Mar, 2021 | 20:05h | UTC

Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil – medRxiv

Commentary: Brazil variant can reinfect virus survivors; COVID-19 vaccine antibodies pass into breast milk – Reuters

Diagnosis of non-consensus transient ischemic attacks with focal, negative, and non-progressive symptoms: population-based validation by investigation and prognosis

7 Mar, 2021 | 19:32h | UTC

Diagnosis of non-consensus transient ischaemic attacks with focal, negative, and non-progressive symptoms: population-based validation by investigation and prognosis – The Lancet

Commentary on Twitter

Some patients present with symptoms that are considered not definitive for TIA (isolated dysarthria, vertigo, etc). Are these patients at risk for later stroke? Fascinating results in @TheLancet from the Oxford Vascular Study@ESOstroke @WorldStrokeOrg https://t.co/l0tJXseE3Y

— Seemant Chaturvedi (@ChaturvediNeuro) March 5, 2021

[Preprint] Increased risk of hospitalization associated with infection with SARS-CoV-2 Lineage B.1.1.7 in Denmark

7 Mar, 2021 | 19:46h | UTC

Increased Risk of Hospitalisation Associated with Infection with SARS-CoV-2 Lineage B.1.1.7 in Denmark – The Lancet

Commentary on Twitter (thread – click for more)

📍~64% MORE SEVERE—The already more contagious #B117 variant from 🇬🇧 is now found to increase risk of #COVID19 hospitalization by 64% versus other strains, says Denmark’s 🇩🇰 CDC. Denmark sequences every cases—their data is the best, & now most worrisome.🧵 https://t.co/F6w2JYEUnM pic.twitter.com/mngJoTBZtl

— Eric Feigl-Ding (@DrEricDing) March 4, 2021